| RS1560568801 |
SGCB
|
Health Risk |
Conflicting classifications of pathogenicity |
Autosomal recessive limb-girdle muscular dystrophy type 2E, Autosomal recessive limb-girdle muscular dystrophy type 2E |
| RS1560570541 |
PPP3CA
|
Health Risk |
Pathogenic |
Developmental and epileptic encephalopathy 91, Developmental and epileptic encephalopathy 91 |
| RS1560570546 |
PPP3CA
|
Health Risk |
Likely pathogenic |
— |
| RS1560588098 |
TTN
|
Health Risk |
Conflicting classifications of pathogenicity |
Dilated cardiomyopathy 1G, Autosomal recessive limb-girdle muscular dystrophy type 2J |
| RS1560590094 |
PITX2
|
Health Risk |
Pathogenic |
Axenfeld-Rieger syndrome type 1, Axenfeld-Rieger syndrome type 1 |
| RS1560592253 |
PKD2
|
Health Risk |
Pathogenic |
Autosomal dominant polycystic kidney disease, Autosomal dominant polycystic kidney disease |
| RS1560597869 |
PKD2
|
Health Risk |
Pathogenic |
Polycystic kidney disease 2, Polycystic kidney disease 2 |
| RS1560597874 |
PKD2
|
Health Risk |
Pathogenic |
— |
| RS1560598042 |
PKD2
|
Health Risk |
Pathogenic |
Polycystic kidney disease 2, Polycystic kidney disease 2 |
| RS1560602156 |
ZEB2
|
Health Risk |
Pathogenic |
— |
| RS1560602214 |
ZEB2
|
Health Risk |
Likely pathogenic |
— |
| RS1560602800 |
NSD2
|
Health Risk |
Pathogenic |
Wolf-Hirschhorn like syndrome, 4p partial monosomy syndrome |
| RS1560604726 |
FRAS1
|
Health Risk |
Pathogenic |
Fraser syndrome 1, Fraser syndrome 1 |
| RS1560604977 |
ZEB2
|
Health Risk |
Pathogenic |
Mowat-Wilson syndrome, Mowat-Wilson syndrome |
| RS1560605892 |
ZEB2
|
Health Risk |
Pathogenic |
Mowat-Wilson syndrome, Mowat-Wilson syndrome |
| RS1560605894 |
ZEB2
|
Health Risk |
Conflicting classifications of pathogenicity |
ZEB2-related disorder, ZEB2-related disorder |
| RS1560606294 |
ZEB2
|
Health Risk |
Pathogenic |
Mowat-Wilson syndrome, Mowat-Wilson syndrome |
| RS1560606974 |
ZEB2
|
Health Risk |
Pathogenic |
Mowat-Wilson syndrome, Mowat-Wilson syndrome |
| RS1560607925 |
ZEB2
|
Health Risk |
Pathogenic |
Mowat-Wilson syndrome, Mowat-Wilson syndrome |
| RS1560608538 |
PKD2
|
Health Risk |
Likely pathogenic |
Polycystic kidney disease 2, Polycystic kidney disease 2 |
| RS1560608729 |
PKD2
|
Health Risk |
Pathogenic |
Polycystic kidney disease 2, Polycystic kidney disease 2 |
| RS1560609721 |
ZEB2
|
Health Risk |
Pathogenic |
Mowat-Wilson syndrome, Mowat-Wilson syndrome |
| RS1560609810 |
ZEB2
|
Health Risk |
Pathogenic |
Mowat-Wilson syndrome, Mowat-Wilson syndrome |
| RS1560614154 |
MTTP
|
Health Risk |
Pathogenic |
Abetalipoproteinaemia, Abetalipoproteinaemia |
| RS1560614646 |
MTTP
|
Health Risk |
Pathogenic/Likely pathogenic |
Abetalipoproteinaemia, Abetalipoproteinaemia |
| RS1560616550 |
CNGA1
|
Health Risk |
Pathogenic/Likely pathogenic |
— |
| RS1560617356 |
PKD2
|
Health Risk |
Likely pathogenic |
Polycystic kidney disease 2, Polycystic kidney disease 2 |
| RS1560618505 |
ZEB2
|
Health Risk |
Pathogenic |
Mowat-Wilson syndrome, Mowat-Wilson syndrome |
| RS1560619891 |
NEB
|
Health Risk |
Likely pathogenic |
Nemaline myopathy 2, Arthrogryposis multiplex congenita 6 |
| RS1560620277 |
PKD2
|
Health Risk |
Pathogenic |
Polycystic kidney disease 2, Polycystic kidney disease 2 |
| RS1560620837 |
ZEB2
|
Health Risk |
Pathogenic |
Mowat-Wilson syndrome, Mowat-Wilson syndrome |
| RS1560621444 |
MTTP
|
Health Risk |
Pathogenic |
Abetalipoproteinaemia, Abetalipoproteinaemia |
| RS1560621750 |
PKD2
|
Health Risk |
Pathogenic |
Polycystic kidney disease 2, Polycystic kidney disease 2 |
| RS1560621807 |
CNGA1
|
Health Risk |
Pathogenic |
Retinitis pigmentosa, Retinitis pigmentosa |
| RS1560625450 |
FRAS1
|
Health Risk |
Pathogenic |
— |
| RS1560625478 |
FRAS1
|
Health Risk |
Pathogenic/Likely pathogenic |
Fraser syndrome 1, Fraser syndrome 1 |
| RS1560626499 |
PKD2
|
Health Risk |
Pathogenic/Likely pathogenic |
Polycystic kidney disease 2, Polycystic kidney disease 2 |
| RS1560626561 |
PKD2
|
Health Risk |
Pathogenic |
Polycystic kidney disease 2, Polycystic kidney disease 2 |
| RS1560627357 |
MTTP
|
Health Risk |
Pathogenic |
— |
| RS1560628245 |
PKD2
|
Health Risk |
Pathogenic |
Polycystic kidney disease 2, Polycystic kidney disease 2 |
| RS1560632930 |
PKD2
|
Health Risk |
Pathogenic |
Polycystic kidney disease, Polycystic kidney disease 2 |
| RS1560635105 |
NSD2
|
Health Risk |
Pathogenic |
Wolf-Hirschhorn like syndrome, 4p partial monosomy syndrome |
| RS1560636155 |
BBS7
|
Health Risk |
Likely pathogenic |
— |
| RS1560638613 |
BBS7
|
Health Risk |
Likely pathogenic |
Bardet-Biedl syndrome, Bardet-Biedl syndrome |
| RS1560647130 |
BBS7
|
Health Risk |
Pathogenic |
— |
| RS1560658189 |
BBS7
|
Health Risk |
Pathogenic |
Bardet-Biedl syndrome, Bardet-Biedl syndrome |
| RS1560664459 |
BBS7
|
Health Risk |
Pathogenic/Likely pathogenic |
Retinal dystrophy, Bardet-Biedl syndrome |
| RS1560667008 |
AFG2A
|
Health Risk |
Pathogenic |
Microcephaly-intellectual disability-sensorineural hearing loss-epilepsy-abnormal muscle tone syndrome, Microcephaly-intellectual disability-sensorineural hearing loss-epilepsy-abnormal muscle tone syndrome |
| RS1560667389 |
SGMS2
|
Health Risk |
Pathogenic/Likely pathogenic |
Calvarial doughnut lesions-bone fragility syndrome, Inborn genetic diseases |
| RS1560667512 |
SGMS2
|
Health Risk |
Pathogenic |
Calvarial doughnut lesions with bone fragility and spondylometaphyseal dysplasia, Calvarial doughnut lesions with bone fragility and spondylometaphyseal dysplasia |
| RS1560667521 |
SGMS2
|
Health Risk |
Pathogenic |
Calvarial doughnut lesions with bone fragility and spondylometaphyseal dysplasia, Calvarial doughnut lesions with bone fragility and spondylometaphyseal dysplasia |
| RS1560669563 |
LIAS
|
Health Risk |
Likely pathogenic |
— |
| RS1560671891 |
BMPR1B
|
Health Risk |
Pathogenic |
Type A2 brachydactyly, Acromesomelic dysplasia 3 |
| RS1560674852 |
LIAS
|
Health Risk |
Conflicting classifications of pathogenicity |
Lipoic acid synthetase deficiency, Lipoic acid synthetase deficiency |
| RS1560679469 |
NFKB1
|
Health Risk |
Pathogenic |
Immunodeficiency, common variable |
| RS1560681144 |
FRAS1
|
Health Risk |
Pathogenic |
— |
| RS1560689563 |
TTN
|
Health Risk |
Likely pathogenic |
Myopathy, myofibrillar |
| RS1560690591 |
GRXCR1
|
Health Risk |
Pathogenic/Likely pathogenic |
Deafness, Hearing loss |
| RS1560692247 |
TTN
|
Health Risk |
Likely pathogenic |
Dilated cardiomyopathy 1G, Autosomal recessive limb-girdle muscular dystrophy type 2J |
| RS1560696317 |
NSD2
|
Health Risk |
Pathogenic |
Wolf-Hirschhorn like syndrome, 4p partial monosomy syndrome |
| RS1560697035 |
PLK4
|
Health Risk |
Pathogenic |
— |
| RS1560701036 |
CYP2U1
|
Health Risk |
Pathogenic |
— |
| RS1560701200 |
CYP2U1;CYP2U1-AS1
|
Health Risk |
Pathogenic/Likely pathogenic |
Hereditary spastic paraplegia 56, Hereditary spastic paraplegia 56 |
| RS1560706306 |
NFKB1
|
Health Risk |
Likely pathogenic |
— |
| RS1560706958 |
BBS12
|
Health Risk |
Pathogenic/Likely pathogenic |
Bardet-Biedl syndrome, Bardet-Biedl syndrome 12 |
| RS1560707540 |
BBS12
|
Health Risk |
Likely pathogenic |
Bardet-Biedl syndrome 12, Bardet-Biedl syndrome 12 |
| RS1560707962 |
BBS12
|
Health Risk |
Likely pathogenic |
Bardet-Biedl syndrome 12, Bardet-Biedl syndrome 12 |
| RS1560708847 |
BBS12
|
Health Risk |
Pathogenic/Likely pathogenic |
Retinal dystrophy, Bardet-Biedl syndrome |
| RS1560710220 |
FRAS1
|
Health Risk |
Pathogenic |
— |
| RS1560711146 |
NFKB1
|
Health Risk |
Likely pathogenic |
Immunodeficiency, common variable |
| RS1560735659 |
NR3C2
|
Health Risk |
Pathogenic |
Autosomal dominant pseudohypoaldosteronism type 1, Autosomal dominant pseudohypoaldosteronism type 1 |
| RS1560739587 |
CLGN
|
Health Risk |
Likely pathogenic |
Short stature, Short stature |
| RS1560747815 |
MFSD8
|
Health Risk |
Likely pathogenic |
Inborn genetic diseases, Inborn genetic diseases |
| RS1560752842 |
MANBA
|
Health Risk |
Pathogenic |
Beta-D-mannosidosis, Beta-D-mannosidosis |
| RS1560755661 |
TBCK
|
Health Risk |
Pathogenic |
Hypotonia, infantile |
| RS1560763939 |
TTN
|
Health Risk |
Conflicting classifications of pathogenicity |
Dilated cardiomyopathy 1G, Autosomal recessive limb-girdle muscular dystrophy type 2J |
| RS1560776422 |
MFSD8
|
Health Risk |
Pathogenic |
Neuronal ceroid lipofuscinosis 7, Neuronal ceroid lipofuscinosis 7 |
| RS1560782372 |
SLC10A7
|
Health Risk |
Pathogenic |
Short stature, amelogenesis imperfecta |
| RS1560786479 |
AFG2A
|
Health Risk |
Pathogenic |
— |
| RS1560786548 |
TTN
|
Health Risk |
Conflicting classifications of pathogenicity |
Dilated cardiomyopathy 1G, Autosomal recessive limb-girdle muscular dystrophy type 2J |
| RS1560795828 |
MMAA
|
Health Risk |
Pathogenic |
Methylmalonic aciduria, cblA type |
| RS1560797350 |
MMAA
|
Health Risk |
Likely pathogenic |
Methylmalonic aciduria, cblA type |
| RS1560802980 |
MMAA
|
Health Risk |
Likely pathogenic |
Methylmalonic aciduria, cblA type |
| RS1560814874 |
SMARCA5
|
Health Risk |
Likely pathogenic |
Short stature, Short stature |
| RS1560833290 |
FGG
|
Health Risk |
Likely pathogenic |
— |
| RS1560841701 |
SLC25A4
|
Health Risk |
Likely pathogenic |
Mitochondrial DNA depletion syndrome 12A (cardiomyopathic type), autosomal dominant |
| RS1560848309 |
NEB
|
Health Risk |
Likely pathogenic |
Nemaline myopathy 2, Nemaline myopathy 2 |
| RS1560870755 |
LRAT
|
Health Risk |
Pathogenic/Likely pathogenic |
Leber congenital amaurosis 14, RETINITIS PIGMENTOSA |
| RS1560871145 |
LRAT
|
Health Risk |
Pathogenic |
— |
| RS1560880125 |
TTN
|
Health Risk |
Likely pathogenic |
Dilated cardiomyopathy 1G, Autosomal recessive limb-girdle muscular dystrophy type 2J |
| RS1560880946 |
TBCK
|
Health Risk |
Pathogenic |
— |
| RS1560894236 |
AFG2A
|
Health Risk |
Likely pathogenic |
Microcephaly-intellectual disability-sensorineural hearing loss-epilepsy-abnormal muscle tone syndrome, Microcephaly-intellectual disability-sensorineural hearing loss-epilepsy-abnormal muscle tone syndrome |
| RS1560902834 |
TTN
|
Health Risk |
Likely pathogenic |
Dilated cardiomyopathy 1G, Autosomal recessive limb-girdle muscular dystrophy type 2J |
| RS1560910156 |
NR3C2
|
Health Risk |
Pathogenic |
Autosomal dominant pseudohypoaldosteronism type 1, Autosomal dominant pseudohypoaldosteronism type 1 |
| RS1560911619 |
TBCK
|
Health Risk |
Pathogenic/Likely pathogenic |
Hypotonia, infantile |
| RS1560914625 |
LRBA
|
Health Risk |
Pathogenic |
Combined immunodeficiency due to LRBA deficiency, Combined immunodeficiency due to LRBA deficiency |
| RS1560918374 |
TTN
|
Health Risk |
Likely pathogenic |
Dilated cardiomyopathy 1G, Autosomal recessive limb-girdle muscular dystrophy type 2J |
| RS1560923303 |
LARP7
|
Health Risk |
Pathogenic/Likely pathogenic |
Microcephalic primordial dwarfism, Alazami type |
| RS1560926034 |
TTN
|
Health Risk |
Likely pathogenic |
Dilated cardiomyopathy 1G, Autosomal recessive limb-girdle muscular dystrophy type 2J |
| RS1560928649 |
NR3C2
|
Health Risk |
Likely pathogenic |
Autosomal dominant pseudohypoaldosteronism type 1, Autosomal dominant pseudohypoaldosteronism type 1 |